109 related articles for article (PubMed ID: 29533972)
21. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
[TBL] [Abstract][Full Text] [Related]
22. Impact of Sonic Hedgehog Pathway Expression on Outcome in HPV Negative Head and Neck Carcinoma Patients after Surgery and Adjuvant Radiotherapy.
Enzenhofer E; Parzefall T; Haymerle G; Schneider S; Kadletz L; Heiduschka G; Pammer J; Oberndorfer F; Wrba F; Loader B; Grasl MC; Perisanidis C; Erovic BM
PLoS One; 2016; 11(12):e0167665. PubMed ID: 27918595
[TBL] [Abstract][Full Text] [Related]
23. Effect of HPV on tumor expression levels of the most commonly used markers in HNSCC.
Polanska H; Heger Z; Gumulec J; Raudenska M; Svobodova M; Balvan J; Fojtu M; Binkova H; Horakova Z; Kostrica R; Adam V; Kizek R; Masarik M
Tumour Biol; 2016 Jun; 37(6):7193-201. PubMed ID: 26666815
[TBL] [Abstract][Full Text] [Related]
24. Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome.
Ronchi CL; Sbiera S; Altieri B; Steinhauer S; Wild V; Bekteshi M; Kroiss M; Fassnacht M; Allolio B
Endocr Relat Cancer; 2015 Aug; 22(4):531-43. PubMed ID: 25979380
[TBL] [Abstract][Full Text] [Related]
25. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.
Franzmann EJ; Schroeder GL; Goodwin WJ; Weed DT; Fisher P; Lokeshwar VB
Int J Cancer; 2003 Sep; 106(3):438-45. PubMed ID: 12845686
[TBL] [Abstract][Full Text] [Related]
26. Activation of Notch signaling in human tongue carcinoma.
Zhang TH; Liu HC; Zhu LJ; Chu M; Liang YJ; Liang LZ; Liao GQ
J Oral Pathol Med; 2011 Jan; 40(1):37-45. PubMed ID: 20819128
[TBL] [Abstract][Full Text] [Related]
27. Notch1 is a 5-fluorouracil resistant and poor survival marker in human esophagus squamous cell carcinomas.
Liu J; Fan H; Ma Y; Liang D; Huang R; Wang J; Zhou F; Kan Q; Ming L; Li H; Giercksky KE; Nesland JM; Suo Z
PLoS One; 2013; 8(2):e56141. PubMed ID: 23409141
[TBL] [Abstract][Full Text] [Related]
28. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
[TBL] [Abstract][Full Text] [Related]
29. Novel markers for poor prognosis in head and neck cancer.
Chin D; Boyle GM; Williams RM; Ferguson K; Pandeya N; Pedley J; Campbell CM; Theile DR; Parsons PG; Coman WB
Int J Cancer; 2005 Feb; 113(5):789-97. PubMed ID: 15499618
[TBL] [Abstract][Full Text] [Related]
30. X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma.
Cao W; Liu J; Xia R; Lin L; Wang X; Xiao M; Zhang C; Li J; Ji T; Chen W
Oncotarget; 2016 Mar; 7(12):14537-50. PubMed ID: 26908444
[TBL] [Abstract][Full Text] [Related]
31. Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma?
Thomas J; Primeaux T
Ann Diagn Pathol; 2012 Apr; 16(2):91-9. PubMed ID: 22197546
[TBL] [Abstract][Full Text] [Related]
32. TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation.
Dixit R; Kemp C; Kulich S; Seethala R; Chiosea S; Ling S; Ha PK; Duvvuri U
Sci Rep; 2015 Nov; 5():16657. PubMed ID: 26563938
[TBL] [Abstract][Full Text] [Related]
33. Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer.
Upadhyay P; Nair S; Kaur E; Aich J; Dani P; Sethunath V; Gardi N; Chandrani P; Godbole M; Sonawane K; Prasad R; Kannan S; Agarwal B; Kane S; Gupta S; Dutt S; Dutt A
Oncotarget; 2016 Aug; 7(31):50437-50449. PubMed ID: 27391340
[TBL] [Abstract][Full Text] [Related]
34. Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients.
Farnebo L; Tiefenböck K; Ansell A; Thunell LK; Garvin S; Roberg K
Int J Cancer; 2013 Oct; 133(8):1994-2003. PubMed ID: 23564498
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
[TBL] [Abstract][Full Text] [Related]
36. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK
BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171
[TBL] [Abstract][Full Text] [Related]
37. Association of SIRT1 and tumor suppressor gene TAp63 expression in head and neck squamous cell carcinoma.
Kikuchi K; Noguchi A; Kasajima R; Miyagi Y; Hoshino D; Koshikawa N; Kubota A; Yokose T; Takano Y
Tumour Biol; 2015 Sep; 36(10):7865-72. PubMed ID: 25946975
[TBL] [Abstract][Full Text] [Related]
38. Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.
Szentkúti G; Dános K; Brauswetter D; Kiszner G; Krenács T; Csákó L; Répássy G; Tamás L
Pathol Oncol Res; 2015 Jul; 21(3):643-50. PubMed ID: 25547827
[TBL] [Abstract][Full Text] [Related]
39. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
40. Notch1 in oral squamous cell carcinoma.
Yoshida R; Ito T; Hassan WA; Nakayama H
Histol Histopathol; 2017 Apr; 32(4):315-323. PubMed ID: 27615693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
